PMC:7647877 / 24480-24608
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T152 | 43-51 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T340 | 32-33 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T341 | 92-93 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T342 | 124-126 | http://purl.obolibrary.org/obo/CLO_0001382 | denotes | 48 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T223 | 74-78 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T152 | 0-128 | Sentence | denotes | Finally, in light of the above, a possible COVID-19 therapy would combine drug therapy with a personalized immunonutrition [48]. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 709 | 43-51 | Disease | denotes | COVID-19 | MESH:C000657245 |